The Official Medtipster Blog

have your healthcare and afford it, too
Subscribe

Paying the highest brand co payment on your prescription drug plan

August 12, 2010 By: PharmaSueAnn Category: Medtipster

Tired of paying the highest brand co payment on your prescription drug plan! Ask your retail pharmacist for alternatives to discuss with your doctor at your next appointment. We are pretty friendly people and love to talk with our patient/customers. Here are just a few:

Brands without generics/therapeutic alternatives with generics
Uroxatrol. Vs. Tamsulosin (Flomax)
Prevacid sol tab vs. Lansoprazole caps (Prevacid)
Nexium vs. Omeprazole(Prilosec)
Ambien CR vs zolpidem (Ambien)

Rx Abandonment on the Rise

March 24, 2010 By: Nadia Category: Medtipster, Prescription News

Rx abandonment on the rise in patients with commercial health plans, market research study said

Medtipster Source: Drug Benefit News – Author: Alaric DeArment

Patients using commercial health plans in 2009 abandoned their prescriptions at a rate 24% higher than in 2008, according to a new report by Wolters Kluwer Pharma Solutions.

The market research firm said consumers were become more price-sensitive toward drugs, particularly branded drugs; as a result, while the overall rate of abandonment was 6.3%, it was 8.6% for branded drugs, a 23% increase over 2008 and a 68% increase over 2006. Together, patient abandonment and denials for new prescriptions by payers meant that 14.4% of prescriptions went unfilled in 2009, a 5.5% increase over 2008.

Additionally, many patients are turning to generics, which accounted for 66% of prescriptions filled in 2009, versus 60% in 2008 and 50% in 2005. In 2009, there were 2.6 billion generic prescriptions filled, compared with 1.3 billion branded prescriptions.

“Today, patients wield more power and are more inclined to exert that influence in decisions about their prescription drugs,” said Wolters Kluwer Pharma Solutions president and CEO Mark Spiers. “During tough economic times, consumers tend to think more with their pocketbooks. We’re seeing increasing price sensitivity to co-pay and broader moves by patients in making decisions about their drug therapy.”

Get Adobe Flash playerPlugin by wpburn.com wordpress themes